| Materials Science | Lifetime | 479 | CN 126 | 99.79 |
| Biological Sciences | 2021-2025 | 33 | CN 10 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 134 | CN 14 | 99.97 |
| Environmental Science and Ecology | 2021-2025 | 250 | CN 115 | 99.78 |
| Materials Science | 2021-2025 | 141 | CN 88 | 99.78 |
| Chemistry | 2021-2025 | 247 | CN 119 | 98.76 |
| Biomedical Engineering | Lifetime | 198 | CN 50 | 99.73 |
| Molecular Biology | Lifetime | 776 | CN 35 | 99.59 |
| Materials Chemistry | Lifetime | 621 | CN 175 | 99.36 |
| Biomaterials | Lifetime | 172 | CN 37 | 99.06 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 506 | CN 10 | 98.72 |
| Pulmonary and Respiratory Medicine | Lifetime | 846 | CN 17 | 98.65 |
| Complementary and Alternative Medicine | Lifetime | 341 | CN 30 | 98.18 |
| Immunology | Lifetime | 590 | CN 16 | 98.23 |
| Organic Chemistry | Lifetime | 849 | CN 95 | 98.14 |
| Oncology | Lifetime | 872 | CN 29 | 98.10 |
| Health, Toxicology and Mutagenesis | Lifetime | 594 | CN 101 | 97.33 |
| Pollution | Lifetime | 510 | CN 132 | 96.34 |
| Infectious Diseases | Lifetime | 843 | CN 28 | 96.00 |
| Developmental Neuroscience | Lifetime | 213 | CN 5 | 93.14 |
| Polymers, Plastics and Soft Materials | Lifetime | 917 | CN 246 | 93.31 |
| Analytical Chemistry | Lifetime | 642 | CN 91 | 91.28 |
| Hematology | Lifetime | 893 | CN 10 | 90.88 |
| Microbiology | Lifetime | 559 | CN 14 | 85.76 |
| Nanoscience and Nanotechnology | Lifetime | 467 | CN 135 | 79.94 |
| Molecular Biology | 2021-2025 | 34 | CN 17 | 99.86 |
| Biomedical Engineering | 2021-2025 | 62 | CN 34 | 99.78 |
| Immunology | 2021-2025 | 28 | CN 5 | 99.38 |
| Biomaterials | 2021-2025 | 32 | CN 11 | 99.11 |
| Surgery | 2021-2025 | 170 | CN 11 | 98.99 |
| Materials Chemistry | 2021-2025 | 171 | CN 108 | 99.33 |
| Oncology | 2021-2025 | 119 | CN 14 | 99.29 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 67 | CN 8 | 98.77 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 129 | CN 19 | 99.15 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 95 | CN 39 | 98.72 |
| Infectious Diseases | 2021-2025 | 116 | CN 17 | 98.10 |
| Pollution | 2021-2025 | 109 | CN 55 | 98.38 |
| Complementary and Alternative Medicine | 2021-2025 | 81 | CN 19 | 97.11 |
| Neuroscience of Neurology | 2021-2025 | 148 | CN 23 | 92.14 |
| Cancer Research | 2021-2025 | 150 | CN 51 | 92.33 |
| Organic Chemistry | 2021-2025 | 336 | CN 126 | 92.89 |
| Microbiology | 2021-2025 | 64 | CN 7 | 91.02 |
| Hematology | 2021-2025 | 251 | CN 6 | 89.89 |
| Analytical Chemistry | 2021-2025 | 158 | CN 43 | 89.13 |
| Pathology and Forensic Medicine | 2021-2025 | 437 | CN 51 | 81.48 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 925 | CN 46 | 80.01 |
| Nanoplatforms for cancer theranostics | Lifetime | 73 | CN 50 | 99.64 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 115 | CN 6 | 99.45 |
| Graphene and Nanomaterials Applications | Lifetime | 63 | CN 24 | 99.47 |
| Nanoparticle-Based Drug Delivery | Lifetime | 84 | CN 28 | 99.53 |
| Advanced Nanomaterials in Catalysis | Lifetime | 122 | CN 79 | 99.31 |
| Nanoparticles: synthesis and applications | Lifetime | 111 | CN 17 | 99.06 |
| Advanced biosensing and bioanalysis techniques | Lifetime | 438 | CN 200 | 99.04 |
| Immune cells in cancer | Lifetime | 202 | CN 20 | 98.76 |
| MicroRNA in disease regulation | Lifetime | 558 | CN 203 | 98.20 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 566 | CN 84 | 98.17 |
| Electrochemical sensors and biosensors | Lifetime | 486 | CN 193 | 98.37 |
| RNA Interference and Gene Delivery | Lifetime | 748 | CN 136 | 98.14 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 685 | CN 28 | 98.28 |
| Cancer Cells and Metastasis | Lifetime | 625 | CN 37 | 97.49 |
| Microplastics and Plastic Pollution | Lifetime | 425 | CN 124 | 97.48 |
| Electrospun Nanofibers in Biomedical Applications | Lifetime | 780 | CN 245 | 97.59 |
| Extracellular vesicles in disease | Lifetime | 526 | CN 160 | 96.09 |
| Traditional Chinese Medicine Analysis | Lifetime | 236 | CN 188 | 96.51 |
| Nanocluster Synthesis and Applications | Lifetime | 453 | CN 243 | 96.88 |
| Carbon and Quantum Dots Applications | Lifetime | 420 | CN 295 | 95.49 |
| Inflammasome and immune disorders | Lifetime | 540 | CN 51 | 95.39 |
| Esophageal Cancer Research and Treatment | Lifetime | 968 | CN 47 | 95.67 |
| Fullerene Chemistry and Applications | Lifetime | 422 | CN 56 | 95.91 |
| Hedgehog Signaling Pathway Studies | Lifetime | 388 | CN 5 | 95.07 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 780 | CN 22 | 96.39 |
| Antimicrobial Peptides and Activities | Lifetime | 815 | CN 81 | 94.76 |
| Ginseng Biological Effects and Applications | Lifetime | 416 | CN 208 | 94.01 |
| Traditional Chinese Medicine Studies | Lifetime | 471 | CN 288 | 91.57 |
| Inflammation biomarkers and pathways | Lifetime | 568 | CN 93 | 76.85 |
| Connective Tissue Growth Factor Research | Lifetime | 683 | CN 81 | 76.18 |
| Natural Compounds in Disease Treatment | Lifetime | 749 | CN 388 | 65.83 |
| Antioxidants, Aging, Portulaca oleracea | Lifetime | 592 | CN 248 | 39.56 |
| Immune cells in cancer | 2021-2025 | 27 | CN 14 | 98.93 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 25 | CN 10 | 99.26 |
| Immunotherapy and Immune Responses | 2021-2025 | 49 | CN 13 | 99.16 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 59 | CN 51 | 99.55 |
| Advanced Nanomaterials in Catalysis | 2021-2025 | 72 | CN 54 | 98.98 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 60 | CN 28 | 97.64 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 153 | CN 42 | 98.46 |
| Graphene and Nanomaterials Applications | 2021-2025 | 69 | CN 11 | 98.18 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 449 | CN 61 | 98.15 |
| Advanced biosensing and bioanalysis techniques | 2021-2025 | 266 | CN 191 | 98.38 |
| Antimicrobial Peptides and Activities | 2021-2025 | 64 | CN 32 | 95.45 |
| Air Quality and Health Impacts | 2021-2025 | 319 | CN 171 | 97.62 |
| Microplastics and Plastic Pollution | 2021-2025 | 256 | CN 106 | 97.14 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 642 | CN 123 | 97.56 |
| RNA Interference and Gene Delivery | 2021-2025 | 240 | CN 127 | 96.02 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 41 | CN 37 | 95.08 |
| Cancer Cells and Metastasis | 2021-2025 | 187 | CN 37 | 93.61 |
| Nanocluster Synthesis and Applications | 2021-2025 | 138 | CN 107 | 95.50 |
| CAR-T cell therapy research | 2021-2025 | 610 | CN 63 | 96.35 |
| Gut microbiota and health | 2021-2025 | 724 | CN 340 | 95.43 |
| Inflammasome and immune disorders | 2021-2025 | 183 | CN 91 | 93.28 |
| Pharmaceutical and Antibiotic Environmental Impacts | 2021-2025 | 350 | CN 211 | 94.89 |
| Electrospun Nanofibers in Biomedical Applications | 2021-2025 | 545 | CN 298 | 94.00 |
| Extracellular vesicles in disease | 2021-2025 | 520 | CN 316 | 93.08 |
| Advanced X-ray and CT Imaging | 2021-2025 | 356 | CN 41 | 93.67 |
| Immune Response and Inflammation | 2021-2025 | 186 | CN 72 | 90.15 |
| Natural product bioactivities and synthesis | 2021-2025 | 240 | CN 118 | 91.01 |
| Nanoparticles: synthesis and applications | 2021-2025 | 471 | CN 58 | 93.31 |
| biodegradable polymer synthesis and properties | 2021-2025 | 637 | CN 229 | 92.62 |
| Recycling and Waste Management Techniques | 2021-2025 | 635 | CN 244 | 92.29 |
| Cancer Mechanisms and Therapy | 2021-2025 | 211 | CN 87 | 88.79 |
| Phagocytosis and Immune Regulation | 2021-2025 | 148 | CN 54 | 86.53 |
| Carbon and Quantum Dots Applications | 2021-2025 | 447 | CN 288 | 90.42 |
| Ginseng Biological Effects and Applications | 2021-2025 | 172 | CN 146 | 87.99 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 322 | CN 81 | 87.62 |
| Lanthanide and Transition Metal Complexes | 2021-2025 | 384 | CN 143 | 89.18 |
| Lung Cancer Research Studies | 2021-2025 | 870 | CN 190 | 90.57 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 738 | CN 108 | 89.56 |
| Air Quality Monitoring and Forecasting | 2021-2025 | 583 | CN 302 | 88.99 |
| Climate Change and Health Impacts | 2021-2025 | 963 | CN 269 | 87.46 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 345 | CN 77 | 85.63 |
| Autophagy in Disease and Therapy | 2021-2025 | 639 | CN 307 | 86.07 |
| Supramolecular Self-Assembly in Materials | 2021-2025 | 389 | CN 219 | 87.73 |
| MRI in cancer diagnosis | 2021-2025 | 704 | CN 186 | 86.01 |
| Environmental remediation with nanomaterials | 2021-2025 | 500 | CN 405 | 86.19 |
| Streptococcal Infections and Treatments | 2021-2025 | 551 | CN 60 | 81.63 |
| Intestinal and Peritoneal Adhesions | 2021-2025 | 193 | CN 36 | 77.35 |
| Cancer therapeutics and mechanisms | 2021-2025 | 606 | CN 92 | 78.86 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 523 | CN 178 | 77.55 |
| Cell Adhesion Molecules Research | 2021-2025 | 628 | CN 82 | 74.05 |
| Neonatal and Maternal Infections | 2021-2025 | 365 | CN 31 | 75.12 |
| vaccines and immunoinformatics approaches | 2021-2025 | 829 | CN 129 | 75.42 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 266 | CN 58 | 74.84 |
| Edible Oils Quality and Analysis | 2021-2025 | 349 | CN 65 | 78.09 |
| Occupational and environmental lung diseases | 2021-2025 | 734 | CN 105 | 73.60 |
| Bacterial Infections and Vaccines | 2021-2025 | 881 | CN 85 | 70.99 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 357 | CN 58 | 66.99 |
| Inflammation biomarkers and pathways | 2021-2025 | 139 | CN 67 | 68.10 |
| Biochemical and Structural Characterization | 2021-2025 | 617 | CN 158 | 63.97 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 841 | CN 347 | 60.65 |
| Traditional Chinese Medicine Studies | 2021-2025 | 671 | CN 495 | 60.05 |
| Immune responses and vaccinations | 2021-2025 | 932 | CN 72 | 56.34 |
| Healthcare and Venom Research | 2021-2025 | 709 | CN 228 | 57.00 |
| Chromatin Remodeling and Cancer | 2021-2025 | 898 | CN 111 | 55.55 |
| Surgical Sutures and Adhesives | 2021-2025 | 824 | CN 441 | 55.88 |
| Natural Compounds in Disease Treatment | 2021-2025 | 261 | CN 220 | 40.55 |
| Hemoglobin structure and function | 2021-2025 | 849 | CN 110 | 30.50 |